These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22452378)

  • 1. Cell targeting peptide conjugation to siRNA polyplexes for effective gene silencing in cardiomyocytes.
    Nam HY; Kim J; Kim SW; Bull DA
    Mol Pharm; 2012 May; 9(5):1302-9. PubMed ID: 22452378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery.
    Nam HY; Kim J; Kim S; Yockman JW; Kim SW; Bull DA
    Biomaterials; 2011 Aug; 32(22):5213-22. PubMed ID: 21501867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium.
    Nam HY; McGinn A; Kim PH; Kim SW; Bull DA
    Biomaterials; 2010 Nov; 31(31):8081-7. PubMed ID: 20674007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
    Mo RH; Zaro JL; Shen WC
    Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyocyte-targeted siRNA delivery by prostaglandin E(2)-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis.
    Kim SH; Jeong JH; Ou M; Yockman JW; Kim SW; Bull DA
    Biomaterials; 2008 Nov; 29(33):4439-46. PubMed ID: 18725170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine).
    Kim SH; Jeong JH; Kim TI; Kim SW; Bull DA
    Mol Pharm; 2009; 6(3):718-26. PubMed ID: 19055368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cholesterol-derived ionic copolymers as potential vectors for gene delivery.
    Sevimli S; Sagnella S; Kavallaris M; Bulmus V; Davis TP
    Biomacromolecules; 2013 Nov; 14(11):4135-49. PubMed ID: 24125032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of elastin-like polypeptide for targeted specific gene delivery in vivo.
    Yi A; Sim D; Lee YJ; Sarangthem V; Park RW
    J Nanobiotechnology; 2020 Jan; 18(1):15. PubMed ID: 31952530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
    Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of polyplexes via polymer crosslinking for efficient siRNA delivery.
    Fröhlich T; Edinger D; Russ V; Wagner E
    Eur J Pharm Sci; 2012 Dec; 47(5):914-20. PubMed ID: 23000380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and characterization of a new peptide vector for short interfering RNA delivery.
    Chen B; Xu W; Pan R; Chen P
    J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence-defined oligoaminoamides for the delivery of siRNAs.
    Lee DJ; Wagner E; Lehto T
    Methods Mol Biol; 2015; 1206():15-27. PubMed ID: 25240883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-apoptotic cardioprotective effects of SHP-1 gene silencing against ischemia-reperfusion injury: use of deoxycholic acid-modified low molecular weight polyethyleneimine as a cardiac siRNA-carrier.
    Kim D; Hong J; Moon HH; Nam HY; Mok H; Jeong JH; Kim SW; Choi D; Kim SH
    J Control Release; 2013 Jun; 168(2):125-34. PubMed ID: 23500061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform.
    Yoo J; Lee D; Gujrati V; Rejinold NS; Lekshmi KM; Uthaman S; Jeong C; Park IK; Jon S; Kim YC
    J Control Release; 2017 Jan; 246():142-154. PubMed ID: 27170226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumoral gene silencing by receptor-targeted combinatorial siRNA polyplexes.
    Lee DJ; He D; Kessel E; Padari K; Kempter S; Lächelt U; Rädler JO; Pooga M; Wagner E
    J Control Release; 2016 Dec; 244(Pt B):280-291. PubMed ID: 27287890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-penetrating peptides for siRNA delivery to glioblastomas.
    Srimanee A; Arvanitidou M; Kim K; Hällbrink M; Langel Ü
    Peptides; 2018 Jun; 104():62-69. PubMed ID: 29684592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small nanosized poly(vinyl benzyl trimethylammonium chloride) based polyplexes for siRNA delivery.
    Lou B; Beztsinna N; Mountrichas G; van den Dikkenberg JB; Pispas S; Hennink WE
    Int J Pharm; 2017 Jun; 525(2):388-396. PubMed ID: 28336456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of PEI-conjugated bio-reducible polymer for efficient gene delivery.
    Nam JP; Kim S; Kim SW
    Int J Pharm; 2018 Jul; 545(1-2):295-305. PubMed ID: 29698820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA and Dicer-substrate siRNA.
    Katas H; Abdul Ghafoor Raja M; Ee LC
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1443-50. PubMed ID: 23962166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of poly(amino ester glycol urethane)/siRNA polyplexes for gene silencing.
    Tseng SJ; Tang SC
    Bioconjug Chem; 2007; 18(5):1383-90. PubMed ID: 17567100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.